Genmab to acquire ProfoundBio in $1.8bn deal to enhance cancer treatment

In a landmark move within the biotechnology sector, Genmab A/S (Nasdaq: GMAB) and ProfoundBio, Inc. have announced a definitive agreement under which Genmab will acquire ... Read More